Skip to content

Studying the Effects of the X10D Shoe on Walking in Healthy Adults Aged 50 to 65

Characterizing the Effects of the X10D Sole on Walking Behavior in Healthy Subjects

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07296913
Enrollment
15
Registered
2025-12-22
Start date
2025-10-03
Completion date
2025-12-19
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the Immediate and Long-lasting Effects of the X10D Sole on Important Aspects of Walking Function in Healthy Participants, Walking

Brief summary

The aim of this study is to characterize the biomechanical effects of the X10D sole using objective, quantitative measurement methods. The walking pattern of many people is becoming increasingly passive, and the muscles of the feet and legs are getting weaker. The X10D shoe is an adapted shoe designed to make walking more active and dynamic again. This study investigates the detailed biomechanical effects of the X10D shoe on the walking pattern of healthy participants. For this purpose, walking with the X10D shoe will be compared with (1) walking in a control shoe with a neutral sole and (2) walking in the participants' everyday sports shoes.

Interventions

DEVICEX10D shoe

In this study, we assess the immediate and long-lasting (3-4 weeks) effects of the X10D shoe on a comprehensive battery of biomechanical parameters during various forms of walking. This will be the first study to provide a detailed characterization of the effects of the X10D shoe on diverse walking parameters in healthy individuals aged 50 to 65 years.

Sponsors

University of Zurich
Lead SponsorOTHER
Balgrist Campus AG
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

The inclusion criteria are: * Healthy subjects aged 50-65 years * Ability to walk at minimum 30 minutes at a regular pace without assistance or breaks * Written informed consent as documented by signature (see informed consent form)

Exclusion criteria

The

Design outcomes

Primary

MeasureTime frame
CoP path during ankle-foot roll-over movement as measured by pressure plates integrated in the treadmillup to 4 weeks

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026